Neonatal abstinence syndrome: Identification and management

Current Paediatrics

Volumn 16, Issue 3, 2006, Pages 172-175

  Kassim, Zainab ^a   Greenough, Anne ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Methadone; Neonatal abstinence syndrome; Phenobarbitone; Withdrawal

Indexed keywords

CHLORPROMAZINE; DIAZEPAM; OPIATE; PAREGORIC; PHENOBARBITAL;

ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; HAIR ANALYSIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERVIEW; LONG TERM CARE; MECONIUM; MULTIPLE DRUG ABUSE; OUTCOME ASSESSMENT; PATIENT POSITIONING; RELAXATION TRAINING; SUBSTANCE ABUSE; TREATMENT DURATION; TREATMENT FAILURE; URINALYSIS; WITHDRAWAL SYNDROME;

EID: 33745126282     PISSN: 09575839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cupe.2006.03.004     Document Type: Article

References (19)

1. Sherwood R.A., Keating J., Kavvadia V., Greenough A., and Peters T.J. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr 158 (1999) 488-492
2. Neonatal drug withdrawal. American academy of pediatrics committee on drugs. Pediatrics 101 (1998) 1079-1088
3. Coghlan D., Milner M., Clark T., et al. Neonatal abstinence syndrome. Ir Med J 92 (1999) 232-233 (236)
4. Johnson K., Greenough A., and Gerada C. Maternal drug use and length of neonatal unit stay. Addiction 98 (2003) 785-789
5. Dashe J.S., Sheffield J.S., Olscher D.A., Todd S.J., Jackson G.L., and Wendel G.D. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 100 (2002) 1244-1249
6. Mpenge K, Johnson K, Greenough A. Substance abuse during pregnancy-long term outcome of exposed infants. Int J Prenatal Perinatal Psychol Med 2006; in press.
7. Shephard R., Greenough A., Johnson K., and Gerada C. Hyperphagia, weight gain and neonatal drug withdrawal. Acta Paediatr 91 (2002) 951-953
8. O'Brien C., Hunt R., and Jeffery H.E. Measurement of movement is an objective method to assist in assessment of opiate withdrawal in newborns. Arch Dis Child Fetal Neonatal Ed 89 (2004) F305-F309
9. Ostrea Jr. E.M., Knapp D.K., Tannenbaum L., et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 138 (2001) 344-348
10. Osterloh J.D., and Lee B.L. Urine drug screening in mothers and newborns. Am J Dis Child 143 (1989) 791-793
11. Ostrea Jr. E.M., Brady M.J., Parks P.M., Asensio D.C., and Naluz A. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr 115 (1989) 474-477
12. Graham K., Koren G., Klein J., Schneiderman J., and Greenwald M. Determination of gestational cocaine exposure by hair analysis. J Am Med Assoc 262 (1989) 3328-3330
13. Osborn D.A., Jeffery H.E., and Cole M.J. Sedatives for opiate withdrawal in newborn infants. Cochrane Database Sys Rev 3 (2005) CD002053
14. Osborn D., Jeffery H., and Cole M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 3 (2005) CD002059
15. Jackson L., Ting A., McKay S., Galea P., and Skeoch C. A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome. Arch Dis Child Fetal Neonatal Ed 89 (2004) F300-F304
16. Kandall S.R., Doberczak T.M., Maner K.R., Strashun R.H., and Korsh D.C. Opiate versus CNS depressant therapy in neonatal abstinence syndrome. Am J Dis Child 137 (1983) 378-382
17. Johnson K., Gerada C., and Greenough A. Treatment of neonatal abstinence syndrome. Arch Dis Fetal Neonatal Ed 88 (2003) F2-F5
18. Finnegan L.P., and Ehrlich S. Maternal drug abuse during pregnancy evaluation and pharmacotherapy for neonatal abstinence. Mod Methods Pharmacol 6 (1990) 255-263
19. Johnson K., Gerada C., and Greenough A. Substance misuse during pregnancy. Br J Psychiatry 183 (2003) 187-189